Publications by authors named "Jindi Lu"

Claim this Profile
E
Evaluation of pharmacokinetics and metabolism of three marine-derived piericidins for guiding drug lead selection.
Weimin Liang, Jindi Lu, Ping Yu, Meiqun Cai, Danni Xie

Chin J Nat Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Metabolism characterization and toxicity of N-hydap, a marine candidate drug for lung cancer therapy by LC-MS method.
Jindi Lu, Weimin Liang, Yiwei Hu, Xi Zhang, Ping Yu

Nat Prod Bioprospect· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel marine-derived anti-acute kidney injury agent targeting peroxiredoxin 1 and its nanodelivery strategy based on ADME optimization.
Ping Yu, Tanwei Gu, Yueyang Rao, Weimin Liang, Xi Zhang, Jindi Lu

Acta Pharm Sin B· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism characterization and toxicity of N-hydap, a marine candidate drug for lung cancer therapy by LC-MS method.
Jindi Lu, Weimin Liang, Yiwei Hu, Xi Zhang, Ping Yu

Nat Prod Bioprospect· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oridonin restores hepatic lipid homeostasis in an LXRα-ATGL/EPT1 axis-dependent manner.
Yulian Chen, Huanguo Jiang, Zhikun Zhan, Jindi Lu, Tanwei Gu

J Pharm Anal· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restoration of lipid homeostasis between TG and PE by the LXRα-ATGL/EPT1 axis ameliorates hepatosteatosis.
Yulian Chen, Huanguo Jiang, Zhikun Zhan, Jindi Lu, Tanwei Gu

Cell Death Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis